The dopamine D3 receptor antagonist YQA14 that inhibits the expression and drug-primed reactivation of morphine-induced conditioned place preference in rats

European Journal of Pharmacology

Volumn 720, Issue 1-3, 2013, Pages 212-217

  Hu, Rongrong ^a,b   Song, Rui ^a   Yang, Rifang ^a   Su, Ruibin ^a   Li, Jin ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Addiction; Conditioned place preference; D3 receptor; Opioid; YQA14

Indexed keywords

DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; MORPHINE; UNCLASSIFIED DRUG; YQA 14;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; DISEASE COURSE; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; REPETITION PRIMING;

ANIMALS; BEHAVIOR, ANIMAL; BENZOXAZOLES; CONDITIONING (PSYCHOLOGY); DOPAMINE ANTAGONISTS; EXTINCTION, PSYCHOLOGICAL; MALE; MORPHINE DEPENDENCE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D3;

EID: 84890116239     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.026     Document Type: Article

References (43)

1. Annual Report of Drug Abuse Monitoring in China, 2011. 〈http://www.sda.gov.cn/WS01/CL0051/73928.htmlâŒ
2. C.R. Ashby Jr., M. Paul, E.L. Gardner, C.A. Heidbreder, and J.J. Hagan Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats Synapse 48 2003 154 156 (Pubitemid 36444341)
3. T.J. Banasikowski, A. Bespalov, K. Drescher, B. Behl, L. Unger, A. Haupt, H. Schoemaker, J.P. Sullivan, G. Gross, and R.J. Beninger Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats J. Pharmacol. Exp. Ther. 335 2010 506 515
4. R.J. Beninger Dissociating the effects of altered dopaminergic function on performance and learning Brain Res. Bull. 23 1989 365 371 (Pubitemid 20008442)
5. R.J. Beninger, and T.J. Banasikowski Dopaminergic mechanism of reward-related incentive learning: focus on the dopamine D(3) receptor Neurotoxic. Res. 14 2008 57 70
6. J.M. Bossert, U.E. Ghitza, L. Lu, D.H. Epstein, and Y. Shaham Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications Eur. J. Pharmacol. 526 2005 36 50 (Pubitemid 41744104)
7. M.L. Bouthenet, E. Souil, M.P. Martres, P. Sokoloff, B. Giros, and J.C. Schwartz Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA Brain Res. 564 1991 203 219
8. S.B. Caine, and G.F. Koob Modulation of cocaine self-administration in the rat through D-3 dopamine receptors Science 260 1993 1814 1816
9. C. Duarte, C. Lefebvre, F. Chaperon, M. Hamon, and M.H. Thiebot Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats Neuropsychopharmacology 28 2003 1903 1915 (Pubitemid 37412101)
10. H. Frances, B. Le Foll, J. Diaz, M. Smirnova, and P. Sokoloff Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice Neuroreport 15 2004 2245 2249 (Pubitemid 39392249)
11. C.A. Heidbreder, E.L. Gardner, Z.X. Xi, P.K. Thanos, M. Mugnaini, J.J. Hagan, and C.R. Ashby Jr. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence Brain Res. Brain Res. Rev. 49 2005 77 105 (Pubitemid 40800164)
12. C.A. Heidbreder, and A.H. Newman Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders Ann. NY Acad. Sci. 1187 2010 4 34
13. S.E. Hyman Addiction: a disease of learning and memory Am. J. Psychiatry 162 2005 1414 1422 (Pubitemid 41105555)
14. P.W. Kalivas, and K. McFarland Brain circuitry and the reinstatement of cocaine-seeking behavior Psychopharmacology (Berl) 168 2003 44 56 (Pubitemid 36851162)
15. B. Le Foll, S.R. Goldberg, and P. Sokoloff The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neuropharmacology 49 2005 525 541 (Pubitemid 41169976)
16. B. Le Foll, J.C. Schwartz, and P. Sokoloff Dopamine D3 receptor agents as potential new medications for drug addiction Eur. Psychiatry 15 2000 140 146 (Pubitemid 30194159)
17. A.I. Leshner Addiction is a brain disease, and it matters Science 278 1997 45 47 (Pubitemid 27446268)
18. T. Li, Y. Hou, C.X. Yan, T. Chen, Y. Zhao, and S.B. Li Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration Neurosci. Lett. 485 2010 256 260
19. G.Y. Lu, N. Wu, Z.L. Zhang, J. Ai, and J. Li Effects of D-cycloserine on extinction and reinstatement of morphine-induced conditioned place preference Neurosci. Lett. 503 2011 196 199
20. G.J. Macdonald, C.L. Branch, M.S. Hadley, C.N. Johnson, D.J. Nash, A.B. Smith, G. Stemp, K.M. Thewlis, A.K. Vong, N.E. Austin, P. Jeffrey, K.Y. Winborn, I. Boyfield, J.J. Hagan, D.N. Middlemiss, C. Reavill, G.J. Riley, J.M. Watson, M. Wood, S.G. Parker, and C.R. Ashby Jr Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido) cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-ben zazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist J. Med. Chem. 46 2003 4952 4964 (Pubitemid 37355955)
21. C. Manzanedo, M.A. Aguilar, M. Rodriguez-Arias, and J. Minarro Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice Behav. Brain Res. 121 2001 189 197 (Pubitemid 32220145)
22. G. Mengod, M.T. Villaro, G.B. Landwehrmeyer, M.I. Martinez-Mir, H.B. Niznik, R.K. Sunahara, P. Seeman, B.F. O'Dowd, A. Probst, and J.M. Palacios Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain Neurochem. Int. 20 Suppl 1992 33S 43S
23. M. Narita, K. Mizuo, H. Mizoguchi, M. Sakata, L.F. Tseng, and T. Suzuki Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion J. Neurosci. 23 2003 1006 1012 (Pubitemid 36206192)
24. A.H. Newman, P. Grundt, and M.A. Nader Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents J. Med. Chem. 48 2005 3663 3679 (Pubitemid 40776839)
25. F. Rodriguez De Fonseca, P. Rubio, J.L. Martin-Calderon, S.B. Caine, G.F. Koob, and M. Navarro The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference Eur. J. Pharmacol. 274 1995 47 55
26. H.D. Schmidt, S.M. Anderson, K.R. Famous, V. Kumaresan, and R.C. Pierce Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking Eur. J. Pharmacol. 526 2005 65 76 (Pubitemid 41744106)
27. Y. Shaham, and J. Stewart Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats Psychopharmacology (Berl) 114 1994 523 527 (Pubitemid 24153505)
28. U. Shalev, J.W. Grimm, and Y. Shaham Neurobiology of relapse to heroin and cocaine seeking: a review Pharmacol. Rev. 54 2002 1 42 (Pubitemid 34208828)
29. U. Shalev, D. Highfield, J. Yap, and Y. Shaham Stress and relapse to drug seeking in rats: studies on the generality of the effect Psychopharmacology (Berl) 150 2000 337 346 (Pubitemid 30447854)
30. U. Shalev, M. Marinelli, M.H. Baumann, P.V. Piazza, and Y. Shaham The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat Psychopharmacology (Berl) 168 2003 170 176 (Pubitemid 36851176)
31. D.R. Sibley, F.J. Monsma Jr., and Y. Shen Molecular neurobiology of dopaminergic receptors Int. Rev. Neurobiol. 35 1993 391 415
32. P. Sokoloff, M. Andrieux, R. Besancon, C. Pilon, M.P. Martres, B. Giros, and J.C. Schwartz Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor Eur. J. Pharmacol. 225 1992 331 337
33. P. Sokoloff, B. Giros, M.P. Martres, M.L. Bouthenet, and J.C. Schwartz Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 347 1990 146 151
34. R. Song, R.F. Yang, N. Wu, R.B. Su, J. Li, X.Q. Peng, X. Li, J. Gaal, Z.X. Xi, and E.L. Gardner YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice Addict. Biol. 17 2012 259 273
35. R. Song, H.Y. Zhang, X. Li, G.H. Bi, E.L. Gardner, and Z.X. Xi Increased vulnerability to cocaine in mice lacking dopamine D3 receptors Proc. Natl. Acad. Sci. USA 109 2012 17675 17680
36. J. Stewart Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking J. Psychiatry Neurosci. 25 2000 125 136 (Pubitemid 30233550)
37. T.M. Tzschentke Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade Addict. Biol. 12 2007 227 462 (Pubitemid 47196347)
38. V. Vazquez, S. Weiss, B. Giros, M.P. Martres, and V. Dauge Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats Psychopharmacology (Berl) 193 2007 475 486 (Pubitemid 47094368)
39. X.Y. Wang, M. Zhao, U.E. Ghitza, Y.Q. Li, and L. Lu Stress impairs reconsolidation of drug memory via glucocorticoid receptors in the basolateral amygdala J. Neurosci. 28 2008 5602 5610
40. K. Wicke, and J. Garcia-Ladona The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors Eur. J. Pharmacol. 424 2001 85 90 (Pubitemid 32718611)
41. M.D. Wood, I. Boyfield, D.J. Nash, F.R. Jewitt, K.Y. Avenell, and G.J. Riley Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor Eur. J. Pharmacol. 407 2000 47 51
42. Z.X. Xi, and E.L. Gardner Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction CNS Drug Rev. 13 2007 240 259 (Pubitemid 47052351)
43. Y.X. Xue, Y.X. Luo, P. Wu, H.S. Shi, L.F. Xue, C. Chen, W.L. Zhu, Z.B. Ding, Y.P. Bao, J. Shi, D.H. Epstein, Y. Shaham, and L. Lu A memory retrieval-extinction procedure to prevent drug craving and relapse Science 336 2012 241 245